NYU SoM
Find a Doctor Home Clinical Trials

NYU School of Medicine - Clinical Trials
Search Cancer Clinical Trials
Title 109493: A double Blind, Randomized, Placebo controlled phase III study to Assess the efficacy of recMAGE-A3 + AS15 Antigen specific cancer immunotherapeutic as adjuvant therapy in patients with resectable MAGE-A3 positive NSCLC 
Protocol Number GSK1572932A 
Study Contact
Name Sorensen, Audrey 
Phone 212 263 2562 
email Audrey.Sorensen@nyumc.org  
Principal Investigator
Name Adams, Sylvia 
Rationale Primary objective is to demonstrate the clinical efficacy to recMAGE-A3 + AS15 versus placebo in NSCLC after complete resection. Secondary objective is to consider the efficacy in the population of patients who did not receive 
Available at: Clinical Cancer Center GCRC Tisch
Intervention Type Therapeutic 
Age Requirement older than 18 years
Gender males and females  
Healthy Subjects? no  
Eligibility Criteria Please refer to attached study protocol below 
URL http://www.med.nyu.edu/nyuci/